Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The "Gonadotropin-releasing hormone axis" is not a specific molecule or receptor but refers to the hypothalamic–pituitary–gonadal (HPG) axis. This is an integrated endocrine system comprising the hypothalamus, pituitary gland, and gonads. The HPG axis regulates key physiological processes including development, reproduction, and aging by coordinating the secretion of hormones such as gonadotropin-releasing hormone (GnRH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), estrogen, and testosterone. It plays a central role in sexual maturation at puberty and ongoing reproductive function in adults. Disruption of this axis can lead to various reproductive disorders. Because it describes an entire hormonal pathway rather than a discrete molecular target like a receptor or enzyme, it is not considered a therapeutic target itself but rather encompasses several potential targets within its components
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Gonadotropin-releasing hormone axis.